Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report

Whether somatostatin analogs for acromegaly improve or worsen a patient's glycemic profile is controversial. A risk of hypoglycemia should be presumed, especially when patients receive insulin therapy, as the package inserts caution. However, a detailed clinical course of such a case has never...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Diabetes Investig
Hoofdauteurs: Tanaka, Sho, Haketa, Akira, Yamamuro, Shun, Suzuki, Toshiko, Kobayashi, Hiroki, Hatanaka, Yoshinari, Ueno, Takahiro, Fukuda, Noboru, Abe, Masanori, Yoshino, Atsuo, Soma, Masayoshi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754526/
https://ncbi.nlm.nih.gov/pubmed/28390105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12675
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items